CRH Medical Co. (CRHM) Rating Increased to Overweight at Morgan Stanley

Morgan Stanley upgraded shares of CRH Medical Co. (NYSEAMERICAN:CRHM) from an equal weight rating to an overweight rating in a research note published on Friday, Marketbeat reports.

Other research analysts have also issued research reports about the company. Royal Bank Of Canada raised CRH Medical from a sector perform rating to an outperform rating in a research report on Friday, July 21st. Scotiabank upgraded CRH Medical from a sector perform rating to a sector outperform rating in a research note on Monday, July 24th. National Bank Financial upgraded CRH Medical from a sector perform rating to an outperform rating in a research note on Friday, August 4th. Canaccord Genuity reduced their target price on CRH Medical from $8.00 to $5.00 and set a buy rating for the company in a research note on Friday, August 4th. Finally, Zacks Investment Research downgraded CRH Medical from a hold rating to a sell rating in a research note on Tuesday, November 14th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus price target of $7.83.

CRH Medical (NYSEAMERICAN CRHM) opened at $1.90 on Friday. CRH Medical has a 1-year low of $1.46 and a 1-year high of $9.25.

WARNING: This piece was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/11/21/crh-medical-co-crhm-rating-increased-to-overweight-at-morgan-stanley.html.

Several institutional investors have recently bought and sold shares of the company. Mawer Investment Management Ltd. raised its holdings in shares of CRH Medical by 25.7% during the 3rd quarter. Mawer Investment Management Ltd. now owns 5,963,519 shares of the company’s stock worth $15,542,000 after buying an additional 1,221,028 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of CRH Medical by 7.7% during the 3rd quarter. Stifel Financial Corp now owns 1,665,839 shares of the company’s stock worth $4,332,000 after buying an additional 119,685 shares in the last quarter. Pembroke Management LTD raised its holdings in shares of CRH Medical by 48.4% during the 2nd quarter. Pembroke Management LTD now owns 1,647,800 shares of the company’s stock worth $12,160,000 after buying an additional 537,200 shares in the last quarter. Fiera Capital Corp raised its holdings in shares of CRH Medical by 39.2% during the 2nd quarter. Fiera Capital Corp now owns 1,451,798 shares of the company’s stock worth $8,247,000 after buying an additional 408,959 shares in the last quarter. Finally, Morgan Stanley raised its holdings in shares of CRH Medical by 102.7% during the 1st quarter. Morgan Stanley now owns 1,288,285 shares of the company’s stock worth $10,564,000 after buying an additional 652,737 shares in the last quarter.

CRH Medical Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical (NYSEAMERICAN:CRHM)

Receive News & Ratings for CRH Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply